these results may be useful in developing a multiple-marker profile of metastatic prostate cancer and for the design of imaging agents , such as monoclonal antibodies , to prominent soluble and particulate prostate glycoproteins .
C0936223
of metastatic prostate cancer
C0033572
prostate